Epithelial cellular adhesion molecule (Ep-CAM) has also been used to ascertain disseminated tumor cells in patients with surgically resectable NSCLC, and circulating levels have been associated with reduced disease-free survival [33,34]. This evidence concerns the gene EPCAM and neoplasm.